MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm10194328

Медицинская библиотека · Journal of clinical medicine · 2021

The Role of Urinary N-Acetyl-β-d-glucosaminidase in Cirrhotic Patients with Acute Kidney Injury: Multicenter, Prospective Cohort Study.

Yoo Jeong-Ju, Kwon Jung Hyun, Kim Young Seok, Nam Soon Woo, Park Ji Won, Kim Hee Yeon, Kim Chang Wook, Shin Seung Kak, Chon Young Eun, Jang Eun Sun, Jeong Sook-Hyang, Lee Jin Woo, Song Do Seon, Yang Jin Mo, Lee Sung Won, Lee Hae Lim, Jung Young Kul, Yim Hyung Joon, Lee Bora, Kim Sang Gyune, Kim Ju Hyun

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: Currently, it is difficult to predict the reversibility of renal function and to discriminate renal parenchymal injury in cirrhotic patients with acute kidney injury (AKI). The aim of this study is to evaluate whether urine N-acetyl-β-d-Glucosaminidase (NAG) can predict the survival and response to terlipressin in cirrhotic patients with AKI.

METHODS

Two hundred sixty-two cirrhotic consecutive patients who developed AKI were prospectively enrolled from 11 tertiary medical centers in Korea between 2016 to 2019. AKI was defined as an increase in serum Cr (SCr) of 0.3 mg/dL or a 50% increase in baseline SCr. Patients diagnosed with hepatorenal syndrome (HRS-AKI) were treated with terlipressin plus albumin.

RESULTS

The patients were 58.8 ± 12.9 years old on average and were predominantly male (72.5%). The mean MELD score was 25.3 ± 9.1. When classified according to the AKI phenotype, there were 119 pre-renal, 52 acute tubular necrosis, 18 miscellaneous, and 73 HRS-AKI patients. However, the urine NAG was not effective at discriminating AKI phenotypes, except for HRS-AKI. The baseline urine NAG increased as the baseline AKI stage increased (p < 0.001). In addition, within the same AKI stage, the urine NAG values were significantly lower in the AKI-resolved group than in the unresolved group. The urine NAG level was significantly lower in living patients compared with those who died or who underwent a liver transplant within 3 months (p = 0.005). In the multivariate analysis, the increased urine NAG was a significant risk factor for the 3-month transplant-free survival (TFS) rate, especially in patients with Child-Pugh class ≤ B or MELD < 24. The urine NAG did not predict the response to terlipressin treatment in patients with HRS.

CONCLUSIONS

Urine NAG is strongly associated with the severity of AKI in patients with liver cirrhosis and is useful for predicting the 3-month TFS.

Для цитирования: Yoo Jeong-Ju, Kwon Jung Hyun, Kim Young Seok, Nam Soon Woo, Park Ji Won, Kim Hee Yeon, Kim Chang Wook, Shin Seung Kak, Chon Young Eun, Jang Eun Sun, Jeong Sook-Hyang, Lee Jin Woo, Song Do Seon, Yang Jin Mo, Lee Sung Won, Lee Hae Lim, Jung Young Kul, Yim Hyung Joon, Lee Bora, Kim Sang Gyune, Kim Ju Hyun. The Role of Urinary N-Acetyl-β-d-glucosaminidase in Cirrhotic Patients with Acute Kidney Injury: Multicenter, Prospective Cohort Study.. Journal of clinical medicine. 2021. DOI: 10.3390/jcm10194328.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.